Data / Form D filings / HERON THERAPEUTICS, INC. /DE/
HERON THERAPEUTICS, INC. /DE/: Form D filings
HERON THERAPEUTICS, INC. /DE/, a biotechnology company in San Diego, CA, filed 5 Form D notices with the SEC between 2009 and 2023. The latest, on August 1, 2023, reports $30 million sold of a $30 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4242 Campus Point Court, Suite 200, San Diego, CA, 92121
- Phone
- (858) 251-4400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 818033
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | New notice | $30,000,000 | $30,000,000 | 7 | Jul 25, 2023 | sec.gov | |
| Aug 10, 2012 | New notice | $53,549,999 | $53,549,999 | 21 | Jul 30, 2012 | sec.gov | |
| Jul 11, 2011 | New notice | $24,000,001 | $24,000,001 | 22 | Jul 1, 2011 | sec.gov | |
| May 13, 2011 | New notice | $4,500,000 | $1,500,000 | $3,000,000 | 4 | May 2, 2011 | sec.gov |
| Nov 5, 2009 | New notice | $16,642,811 | $8,142,817 | $8,499,994 | 7 | Oct 22, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Kotler | Director | |
| Ira Duarte | Executive Officer | |
| Christian Waage | Director | |
| Craig Johnson | Director | |
| Sharmila Dissanaike | Director | |
| Adam Morgan | Director | |
| Craig Collard | Executive Officer, Director | |
| Susan Rodriguez | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what HERON THERAPEUTICS, INC. /DE/ reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.